<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/styles/rss-style.xsl"?>

<rss version="2.0"
 xmlns:blogChannel="http://backend.userland.com/blogChannelModule"
>

<channel>
<title>teodesian.net</title>
<link>http://teodesian.net//posts/8c458f40-7a85-472f-88df-c71cdf8e2836?format=xml</link>
<description>teodesian.net : /posts/8c458f40-7a85-472f-88df-c71cdf8e2836</description>
<language>en</language>
<pubDate>2026-04-06T11:21:24</pubDate>
<lastBuildDate>2026-04-06T11:21:24</lastBuildDate>

<image>
<title>teodesian.net</title>
<url>/favicon.ico</url>
<link>http://teodesian.net</link>
<width>32</width>
<height>32</height>
<description>teodesian.net favicon</description>
</image>
<item>
<title>Anticancer immunotherapy: works</title>
<link>http://teodesian.net/posts/8c458f40-7a85-472f-88df-c71cdf8e2836</link>
<description><![CDATA[Of course the FDA will keep it away from practice for at least another decade, if not half-century.]]></description>
<author>doge</author>
<guid isPermaLink="true">http://teodesian.net/posts/8c458f40-7a85-472f-88df-c71cdf8e2836</guid>
<pubDate>2024-07-15T20:04:21</pubDate>
<enclosure type="text/html" url="http://teodesian.net/posts/8c458f40-7a85-472f-88df-c71cdf8e2836" />
</item>
</channel>
</rss>
